Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis

被引:75
|
作者
Ward, MM
机构
[1] VA Palo Alto Hlth Care Syst 111G, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA
关键词
lupus nephritis; renal transplantation; end-stage renal disease; USRDS;
D O I
10.1046/j.1523-1755.2000.00065.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Although the outcomes of renal transplantation among patients with end-stage renal disease (ESRD) caused by lupus nephritis have generally been found to be comparable to those of patients with other causes of ESRD, some studies indicate that cadaveric graft failure is more common among these patients. However, most previous studies examined small numbers of patients and did not adjust for important confounding factors. Methods. Graft failure and patient mortality after the first cadaveric renal transplantation were compared between 772 adults with ESRD caused by lupus nephritis and 32,644 adults with ESRD caused by other causes who received a transplant between 1987 and 1994 and were included in the United States Renal Data System. The median follow-up times were 4.9 and 5.0 years in the two groups, respectively. Multivariate Cox regression models were used to adjust the risks of graft failure and mortality for group differences in recipient and donor characteristics. Similar comparisons were performed between 390 adults with ESRD caused by lupus nephritis and 10,512 adults with ESRD caused by other causes after first living-related renal transplantation. Results. In an unadjusted analysis, the risk of graft failure after first cadaveric transplant was slightly but significantly greater among patients with ESRD caused by lupus nephritis than among those with ESRD caused by other causes [hazard ratio (HR), 1.13; 95% CI, 1.01 to 1.26, P = 0.04]. However, after adjustment for potential confounding factors, the risk of graft failure was not increased in patients with ESRD caused by lupus nephritis (HR, 1.08; 95% CI, 0.94 to 1.23, P = 0.28). Mortality after the first cadaveric transplantation did not differ between groups. The adjusted risks of graft failure (HR, 1.06; 95% CI, 0.84 to 1.32, P = 0.62) and patient mortality (HR = 0.69; 95% CI, 0.45 to 1.05, P = 0.09) after the first living-related renal transplant were also not significantly higher among patients with ESRD caused by lupus nephritis. Conclusions. Graft and patient survival after first cadaveric and first living-related renal transplants are similar in patients with ESRD caused by lupus nephritis and patients with ESRD from other causes.
引用
收藏
页码:2136 / 2143
页数:8
相关论文
共 50 条
  • [21] Prognostic Factors of the Progression of Chronic Kidney Disease and the Development of End-Stage Renal Disease in Patients with Lupus Nephritis: A Retrospective Cohort Study
    Perge, Bianka
    Papp, Gabor
    Boi, Bernadett
    Markoth, Csilla
    Bidiga, Laszlo
    Farmasi, Nikolett
    Balla, Jozsef
    Tarr, Tunde
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [22] Changes of Left Ventricular Mass Index Among End-Stage Renal Disease Patients After Renal Transplantation
    Namazi, Mohammad Hassan
    Parsa, Saeed Alipour
    Hosseini, Banafshe
    Saadat, Habibollah
    Safi, Morteza
    Motamedi, Mohammad Reza
    Vakili, Hossein
    UROLOGY JOURNAL, 2010, 7 (02) : 105 - 109
  • [23] Predictors of mortality and end stage renal disease in Saudi patients with lupus nephritis
    Al Durahim, H.
    Al Ghamdi, G.
    Al Seraya, A.
    Alkhiari, R.
    Al Sayyari, A.
    LUPUS, 2011, 20 (12) : 1329 - 1335
  • [24] Extent and Severity of Coronary Disease and Mortality in Patients with End-Stage Renal Failure Evaluated for Renal Transplantation
    Jones, D. G.
    Taylor, A. M.
    Enkiri, S. A.
    Lobo, P.
    Brayman, K. L.
    Keeley, E. C.
    Lipson, L. C.
    Gimple, L. W.
    Ragosta, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (08) : 1846 - 1852
  • [25] Risk of end-stage renal disease in patients with early-onset lupus nephritis: A population-based cohort study
    Cho, Soo-Kyung
    Kim, Hyoungyoung
    Han, Jung-Yong
    Jeon, Yena
    Jung, Sun-Young
    Jang, Eun Jin
    Sung, Yoon-Kyoung
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 63
  • [26] Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation
    Welsh, Robert C.
    Cockfield, Sandra M.
    Campbell, Patrica
    Hervas-Malo, Marilou
    Gyenes, Gabor
    Dzavik, Vladamir
    TRANSPLANTATION, 2011, 91 (02) : 213 - 218
  • [27] Lupus Nephritis in Males: Clinical Features, Course, and Prognostic Factors for End-Stage Renal Disease
    Urrestaraz, Andres
    Otatti, Gabriela
    Silvarino, Ricardo
    Garau, Mariela
    Coitino, Ruben
    Alvarez, Asuncion
    Gonzalez, Esther
    Gadola, Liliana
    Praga, Manuel
    Noboa, Oscar
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (05): : 905 - 912
  • [28] Contemporary estimates of the risk of end-stage renal disease in the first decade of proliferative lupus nephritis
    MM Ward
    M Tektonidou
    Arthritis Research & Therapy, 14 (Suppl 3):
  • [29] Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry
    Plantinga, Laura C.
    Drenkard, Cristina
    Pastan, Stephen O.
    Lim, S. Sam
    LUPUS SCIENCE & MEDICINE, 2016, 3 (01):
  • [30] Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation
    Swai, Joel
    Zhao Xiexiong
    Noube, Julie-Raisa
    Ming Gui
    BMC NEPHROLOGY, 2020, 21 (01)